Daiichi Sankyo Inc Drug Patent Portfolio

Daiichi Sankyo Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Daiichi Sankyo Inc News

Federal Circuit Invalidates Life Sciences Patent Due to Inadequate Disclosure of Specific Species

16 Jan, 2026

Federal Circuit Invalidates Life Sciences Patent Due to Inadequate Disclosure of Specific Species

16 Jan, 2026

Daiichi Sankyo of Japan plans to expand its production facilities in China and the United States due to potential tariff concerns - Nikkei Asia

02 Jan, 2026

AZN and Daiichi's Enhertu Receives Breakthrough Designation for Broader Cancer Application - TradingView

22 Dec, 2025

See More